Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

SPECT/CT in sentinel node imaging.

Wagner T, Buscombe J, Gnanasegaran G, Navalkissoor S.

Nucl Med Commun. 2013 Mar;34(3):191-202. doi: 10.1097/MNM.0b013e32835c5a24. Review.

PMID:
23276829
2.

SPECT-CT for topographic mapping of sentinel lymph nodes prior to gamma probe-guided biopsy in head and neck squamous cell carcinoma.

Wagner A, Schicho K, Glaser C, Zettinig G, Yerit K, Lang S, Klug C, Leitha T.

J Craniomaxillofac Surg. 2004 Dec;32(6):343-9.

PMID:
15555515
3.

Contribution of SPECT/CT imaging to radioguided sentinel lymph node biopsy in breast cancer, melanoma, and other solid cancers: from "open and see" to "see and open".

Valdés Olmos RA, Rietbergen DD, Vidal-Sicart S, Manca G, Giammarile F, Mariani G.

Q J Nucl Med Mol Imaging. 2014 Jun;58(2):127-39. Review.

PMID:
24835289
4.

A critical reappraisal of false negative sentinel lymph node biopsy in melanoma.

Manca G, Romanini A, Rubello D, Mazzarri S, Boni G, Chiacchio S, Tredici M, Duce V, Tardelli E, Volterrani D, Mariani G.

Q J Nucl Med Mol Imaging. 2014 Jun;58(2):105-13. Review.

PMID:
24835287
5.

[Utility of single photon emission computed tomography-computed tomography in selective sentinel lymph node biopsy in patients with melanoma].

Martínez Castillo R, Fernández López R, Acevedo Bañez I, Alvarez Pérez RM, García Solis D, Vázquez Albertino R, Fernández Ortega P.

Rev Esp Med Nucl Imagen Mol. 2014 May-Jun;33(3):129-35. doi: 10.1016/j.remn.2013.07.012. Epub 2013 Oct 2. Spanish.

6.

Sentinel lymph node mapping in breast cancer: a critical reappraisal of the internal mammary chain issue.

Manca G, Volterrani D, Mazzarri S, Duce V, Svirydenka A, Giuliano A, Mariani G.

Q J Nucl Med Mol Imaging. 2014 Jun;58(2):114-26. Review.

PMID:
24835288
7.

Single-photon emission computed tomography/computed tomographyfor sentinel node mapping in breast cancer.

Husarik DB, Steinert HC.

Semin Nucl Med. 2007 Jan;37(1):29-33. Review.

PMID:
17161037
8.
9.

Sentinel node mapping in vulvovaginal melanoma using SPECT/CT lymphoscintigraphy.

Kobayashi K, Ramirez PT, Kim EE, Levenback CF, Rohren EM, Frumovitz M, Mar MV, Gayed IW.

Clin Nucl Med. 2009 Dec;34(12):859-61. doi: 10.1097/RLU.0b013e3181becdaf.

PMID:
20139817
10.

Utility of hybrid SPECT/CT in primary melanoma lymphoscintigraphy: A retrospective case series.

Tew K, Farlow D.

J Med Imaging Radiat Oncol. 2017 Apr;61(2):204-211. doi: 10.1111/1754-9485.12554. Epub 2016 Nov 14.

PMID:
27863028
11.

Lymphoscintigraphic sentinel node identification in patients with breast cancer: the role of SPECT-CT.

Lerman H, Metser U, Lievshitz G, Sperber F, Shneebaum S, Even-Sapir E.

Eur J Nucl Med Mol Imaging. 2006 Mar;33(3):329-37. Epub 2005 Oct 12.

PMID:
16220303
12.

The predictive value of single-photon emission computed tomography/computed tomography for sentinel lymph node localization in head and neck cutaneous malignancy.

Remenschneider AK, Dilger AE, Wang Y, Palmer EL, Scott JA, Emerick KS.

Laryngoscope. 2015 Apr;125(4):877-82. doi: 10.1002/lary.25024. Epub 2014 Nov 12.

PMID:
25388656
13.

The Hybrid SPECT/CT as an additional lymphatic mapping tool in patients with breast cancer.

van der Ploeg IM, Valdés Olmos RA, Kroon BB, Nieweg OE.

World J Surg. 2008 Sep;32(9):1930-4. doi: 10.1007/s00268-008-9618-5. Review.

14.

Detection of lymph node metastases in pediatric and adolescent/young adult sarcoma: Sentinel lymph node biopsy versus fludeoxyglucose positron emission tomography imaging-A prospective trial.

Wagner LM, Kremer N, Gelfand MJ, Sharp SE, Turpin BK, Nagarajan R, Tiao GM, Pressey JG, Yin J, Dasgupta R.

Cancer. 2017 Jan 1;123(1):155-160. doi: 10.1002/cncr.30282. Epub 2016 Aug 26.

15.

Results of a Prospective Multicenter International Atomic Energy Agency Sentinel Node Trial on the Value of SPECT/CT Over Planar Imaging in Various Malignancies.

Jimenez-Heffernan A, Ellmann A, Sado H, Huić D, Bal C, Parameswaran R, Giammarile F, Pruzzo R, Kostadinova I, Vorster M, Almeida P, Santiago J, Gambhir S, Sergieva S, Calderon A, Young GO, Valdes-Olmos R, Zaknun J, Magboo VP, Pascual TN.

J Nucl Med. 2015 Sep;56(9):1338-44. doi: 10.2967/jnumed.114.153643. Epub 2015 Jul 30.

16.
17.

Comparing the hybrid fluorescent-radioactive tracer indocyanine green-99mTc-nanocolloid with 99mTc-nanocolloid for sentinel node identification: a validation study using lymphoscintigraphy and SPECT/CT.

Brouwer OR, Buckle T, Vermeeren L, Klop WM, Balm AJ, van der Poel HG, van Rhijn BW, Horenblas S, Nieweg OE, van Leeuwen FW, Valdés Olmos RA.

J Nucl Med. 2012 Jul;53(7):1034-40. doi: 10.2967/jnumed.112.103127. Epub 2012 May 29.

18.

SPECT/CT for sentinel lymph node mapping in head and neck melanoma.

Vermeeren L, Valdés Olmos RA, Klop WM, van der Ploeg IM, Nieweg OE, Balm AJ, van den Brekel MW.

Head Neck. 2011 Jan;33(1):1-6. doi: 10.1002/hed.21392.

PMID:
20848414
19.

Sentinel Node Mapping in Melanoma of the Back: SPECT/CT Helps Discriminate "True" and "False" in-Transit Lymph Nodes.

Duce V, Manca G, Mazzarri S, Lorenzetti F, Colletti PM, Rubello D, Volterrani D.

Clin Nucl Med. 2016 Jan;41(1):e66-7. doi: 10.1097/RLU.0000000000000838.

PMID:
26053715
20.

The role of hybrid SPECT/CT for lymphatic mapping in patients with melanoma.

Fairbairn N, Munson C, Khan ZA, Butterworth M.

J Plast Reconstr Aesthet Surg. 2013 Sep;66(9):1248-55. doi: 10.1016/j.bjps.2013.04.062. Epub 2013 May 20.

PMID:
23697997

Supplemental Content

Support Center